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Case series
Abstract
Low and middle-income countries including those in sub-Saharan (SSA) 
Africa are experiencing a steady increase in the number of COVID-19 
cases. To the best of our knowledge, reports of COVID-19 related 
strokes are scarce in SSA. The peculiar situation of stroke care in SSA 
makes COVID-19 associated stroke a bothersome entity as it adds other 
dynamics that tilt the prognostic balance. We present a case series of 
COVID -19 related stroke in 3 patients from Tanzania. We emphasized 
protected code stroke protocol.
Introduction
No doubt, SARS-CoV-2 infection and the coronavirus disease 2019 
(COVID-19) is having a far reaching disruption of communities, countries 
and indeed, the global healthcare work force [1] Following the upsurge 
of cases outside China, in America as well as Europe, low and middle 
income countries (LMIC) including those in sub-Saharan Africa (SSA) 
are experiencing a steady increase in the number of COVID-19 cases. 
Health care institutions in SSA have not been insulated from the direct 
and collateral effect of the COVID 19 pandemic. 16th March 2020, 
Tanzania recorded the first case of COVID-19 [2]. Cases of the condition 
have since increased. Even though a rise in COVID-19 cases is being 
witnessed, they are in no way proportionate to the number of cases in 
the aforementioned continents. COVID-19 cases present with quite an 
array of systemic involvements [3]; including neurological features [4] 
but reports of COVID-19 related strokes are scarce in SSA. In this paper, 
we have presented 3 case reports of radiologically confirmed stroke cases 
in the setting of polymerase chain reaction (PCR)-confirmed SARS-CoV-2 
infection.
Methods
An audit of the patients with acute strokes who presented to the 
emergency department (ED) of the Aga Khan Hospital Dar es salaam 
(AKHD), Tanzania since April 1, 2020 was conducted. A chart review of 
patients with radiological confirmation of acute stroke and concomitant 
COVID-19 infection was performed.
Results
Case 1: 63-year-old male patient with background Diabetes mellitus 
(DM) and hypertension who was irregular on medication was brought 
to the emergency department (ED) with loss of power on his right side 
associated with progressive decline in mentation spanning 4 days. He 
had no previous transient ischemic attack. He did no smoke or drink 
alcoholic beverages. No cough, fever or respiratory symptoms were 
reported. No recent travel history or close contact with a sick person was 
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2established. On examination the patient´s consciousness was impaired, 
Glasgow coma scale (GCS) was 12 (best eye opening 4, best verbal 3, 
and best motor 5). On admission, the temperature was 36.70 C, pulse 
was 82 per minutes and blood pressure (BP) was 170/100 mmHg, pulse 
rate (PR) 82 b/min in normal sinus rhythm and was saturating well on 
room air at 97%. The admission NIHSS score was 26. Patient had right 
hemiparesis (power was 1/5 in the upper and lower limbs), down going 
planter response and depressed deep tendon reflex on the right side. He 
had no sign of meningeal irritation. On respiratory examination, he had 
coarse crepitations bilaterally. Other aspects of the cardiovascular and 
abdominal examination were essentially normal. A computed tomography 
(CT) confirmed left middle cerebral arterial infarct (Figure 1 A). A chest 
x-ray done on admission revealed patchy peripheral faint ground glass 
shadowing (Figure 1 B). Electrocardiogram (ECG) revealed left ventricular 
hypertrophy. At the ED, the patient received aspirin 75mg, clopidogrel 
150mg, and atorvastatin 40 mg in addition to intravenous fluid. 
He was thereafter admitted to the medical ward for continuity of 
care. Because of his x-ray findings, a possibility of COVID-19 was 
entertained hence; we commenced the hospital´s COVID- 19 protocol of 
management. We commenced him on intravenous ceftriaxone 1000mg 
twice a day, azithromycin 500 mg per- oral once a day, vitamin C 1000 
mg per- oral twice a day, vitamin D 500 IU per- oral once a day, zinc 
60 mg per- oral once a day (all via nasogastric tube). Subcutaneous 
heparin was also started at 5000 IU twice a day for thromboprophylaxis. 
His blood work up revealed significant leukocytosis with lymphopaenia, 
deranged renal function (Blood urea nitrogen, BUN was 26.16 mmol/l, 
Creatinine was 242.11 umol/l) and C-reactive protein was elevated to 
153.03mg/l (Table 1).The patient´s condition grew progressively worse 
over a period of 24 hours. His GCS dropped to 10/15, he developed 
respiratory difficulty and worsening of kidney function. COVID-19 was 
later confirmed by nasopharyngeal and oropharyngeal swab using 
real-time reverse transcription PCR. The family was counseled on the 
prognosis and informed about mechanical ventilation and dialysis as the 
next step in management. However, the family chose not to escalate 
treatment and opted for comfort care. The Patient eventually passed 
away after few hours. 
Table 1: initial laboratory results of the cases
Haematological Parameters Patient 1 Patient 2 Patient 3
White blood cell count (4.0 -11* 109/L 10.51 10.85 12.95
Neutrophils Absolute count (1.7-5.38) 9.22 7.77 10.60
Lymphocytes Absolute count (20.0-40.0) 0.67 18.2 1.68
Platelet count (150-450* 109/L) 406 177 349
Hemoglobin (14.0-17.5 g/dL) 12.8 15.5 10.9
Creatinine (59-104 umol/l) 242.11 128.76 136.78
BUN (2.76-8.07 mmol/l) 26.16 11.15 11.73
Prothrombin Time (control 11.8 seconds) 12.2 18.9 N/A
Activated partial thromboplastin (control 23.2
seconds)
23.2 24.3 N/A
D- Dimer (0-0.5 ug/ml) 7.3 6.52 6.20
Ferritin (22-322 ug/l) 1024 463 2601
Lactate Dehydrogenase (135-225 IU/L) 414 848 528.42
C- Reactive Protein serum (0.5-5 mg/L) 153 91.98 312
Procalcitonin 0.89 0.76 >100
Glycated hemoglobin (HB1Ac) 11.40% N/A 10.24%
Total cholesterol (mmol/l) 3.39 5.50 2.69
Triglycerides (mmol/l) 1.60 1.27 2.45
HDL (>1.68 mmol/l No risk, 1.15-1.68 moderate
risk, <1.15 high risk)
0.78 0.80 0.46
LDL (<optimal >2.59 mmol/l, Borderline 2.59 -3.34,
Borderline high 3.37-4.12, high > 4.14)
1.88 4.22 1.12
VLDL 0.73 0.58 1.11
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3Case 2: a 38-year-old male recently diagnosed with heart failure, a month 
prior to admission, was brought to our ED with complaints of a weeklong 
history of acute left-sided weakness. He had also developed progressive 
altered mentation associated with fecal and urinary incontinence. 
Two days prior admission, he developed some degree of difficulty in 
breathing. On examination, he had a GCS of 9/15, NIHSS score was 
28. His blood pressure was 109/56 mm Hg, pulse rate of 88 beats/
min, oxygen saturation of 90% on room air, temperature of 37°C and 
a respiratory rate of 24 breaths/min. Auscultation of the chest revealed 
bilateral mild transmitted sounds. Patient´s brain magnetic resonance 
imaging (MRI) showed right temporal-parietal ischemic stroke with 
hemorrhagic transformation (Figure 2 A) as well as cerebellar infarcts 
(Figure 2 B). He was adjudged to have a cardio-embolic stroke in view 
of the multi-territorial distribution of the infarct. An x-ray of the chest 
revealed poorly defined infiltrates in the right upper zone suggestive of 
pneumonic changes (Figure 2 C). His laboratory tests are detailed in 
Table 1. A positive nitrite with 15-45 pus cells/hpf were noted in his 
urine analysis. The patient was admitted to the high-dependency unit 
of the isolation ward. He was supplemented with 10L/min of oxygen 
with a non-rebreather mask which resulted in improved saturation of 
99%. He was started on intravenous ceftriaxone at 2000 mg once daily 
and metronidazole at a dose of 500 mg 8-hourly for possible aspiration 
pneumonia. Anti-platelets were held temporarily due to the hemorrhagic 
infarct. He was also started on oral Vitamin C 2000 mg once daily, Vitamin 
D 5000 IU once daily, Zinc 60 mg once daily via nasogastric tube. He was 
commenced on subcutaneous Enoxaparin 40 mg daily. A nasopharyngeal 
swab for SARS-Cov-2 PCR came back positive. Over a period of 72 hours 
the patient did not improve even with higher supplemental oxygen. The 
family opted for palliative care and no further tests were conducted. The 
patient succumbed a few hours after. 
Figure 1: (A) non-contrast CT Head demonstrates left middle cerebral artery territory infarct with pressure effect effacing cortical sulci and ipsilateral 
lateral ventricle anterior horn; (B) AP chest X-ray revealed features of right lung pneumonia seen as patchy peripheral faint ground glass shadowing 
in the right lower zone
Figure 2: (A) GRE Haem sequence demonstrates low signal intensity in the region of right basal ganglia representing haemorrhagic transformation; 
(B) MRI DWI shows multiple hyperintense areas of restricted diffusion in the cerebellum in keeping with acute infarctions; (C): chest X-ray, AP reveals 
poorly defined infiltrates in the right upper zones suggestive of pneumonic changes
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4Case 3: this is a 63-year-old male patient known to have hypertension 
(>10 years) on nifedipine 20 mg twice a day. He was recently diagnosed 
with diabetes mellitus but irregular with the use of oral anti-diabetic 
medications. He was brought to the ED with a ten-day history of 
generalized body weakness associated with an intermittent non-
productive cough. He had used some home remedies with no significant 
improvement. His clinical condition worsened with marked left sided 
body weakness and associated shortness of breath. Initial vital signs 
were significant for elevated blood pressure 170/100mmHg, with pulse 
rate of 94 b/min and regular. He was found to be desaturating to as 
low as 86% on room air. The Neurological examination was significant 
for central type facial weakness, depressed gag reflex, left hemiparesis 
(power 2/5) and left hypoaesthesia. His NIHSS score was 19. Respiratory 
examination was significant for bilateral crepitations from mid to lower 
zones, while cardiovascular examination revealed a displaced apex beat 
at 6th intercostal space, mid-clavicular line. The patient´s brain MRI and 
MRA revealed an acute right middle cerebral arterial infarct (Figure 3 A) 
and extensive right internal carotid artery stenosis (Figure 3 B) Laboratory 
work up (Table 1) was significant for neutrophylic leucocytosis, increased 
ferritin and lactate dehydrogenase. An x-ray of the chest (Figure 3 C) was 
suggestive of interstitial edema, while echocardiography on admission 
revealed features suggestive of left ventricular hypertrophy and global 
hypokinesia with ejection fraction of 40%. A nasopharyngeal swab for 
SARS-Cov-2 PCR was taken on admission, which came back positive. 
The patient was admitted to the high-dependency unit of the isolation 
ward and was supplemented with 4L/min of oxygen with nasal prong 
to maintain saturation above 95%. He was started on intravenous 
Ceftriaxone at the dose of 1000 mg twice daily, oral Vitamin C 2000 
mg once daily, Vitamin D 5000 IU once daily, Zinc 60 mg once daily 
and subcutaneous Enoxaparin 40 mg daily. In addition, daily bisoprolol 
2.5 mg, losartan 50 mg, frusemide 40 mg, and eplerenone 25 mg were 
commenced on account of his heart failure. Patient´s blood sugar was 
well controlled with subcutaneous Insulin glargine 20 IU and sitagliptin 
100 mg once a day. The patient improved over the course of admission; 
maintaining saturation of above 95% on room air, with good glycaemic 
and blood pressure control. He was subsequently discharged from the 
general ward 72 hours later for self-isolation. A repeat nasopharyngeal 
swab for SARS-Cov-2 PCR 14 days after discharge was negative.
Discussion
We have reported 3 patients with COVID-19 associated ischaemic strokes. 
To the best of our knowledge, this the first series of COVID-19 related 
stroke in SSA. It is already known that the clinical course of COVID-19 
is most severe among the elderly, the male gender, and patients with 
underlying conditions; particularly diabetes, hypertension and metabolic 
syndrome [5]. Our patients were all males (2 elderlies and 1 young man) 
who had comorbid conditions (diabetes, hypertension, heart failure). 
Although previous reports suggest that the average time of onset of stroke 
after COVID-19 diagnosis was 12 days, [6] two cases actually had stroke 
as their first diagnoses in our series. Indeed, the first case reported no 
cough. However, his progressive decline and desaturation in the intensive 
care informed the clinical decision to test for COVID-19; he had only been 
ill for 4 days. Elevated D-dimer, low HDL and late presentation stand out 
as denominators for these patients. Late presentation of stroke cases to 
the ED is commonplace in SSA prior to the pandemic. However, there 
is a recent change in the health seeking behaviour during this era. This 
could be related to a smaller proportion of patients seeking healthcare 
services for milder symptoms [7]. The “stay at home” mantra appears to 
influence this. 
The interaction between infections and stroke has been well established 
[8]. Systemic infections may cause ischaemic or haemorrhagic stroke 
by direct vascular invasion, thrombosis, or vasculitis. Viral respiratory 
infections may increase the susceptibility to stroke by inducing a 
systemic inflammatory response that can lead to a hypercoagulable 
state, destabilization of pre-existing atherosclerotic plaques, and local 
thrombosis [8] In COVID-19 patients, endothelium damage mimicking 
vasculitis could be seen in severe cases [9] In limited autopsy samples, 
congestions of alveolar septal blood vessels and lymphocytes/monocytes 
infiltration within and around blood vessels have been described. In 
addition, small blood vessels did show hyperplasia, vessel wall thickening, 
lumen stenosis, occlusion and focal haemorrhage. A proportion 
of the severe cases had hyaline thrombi of micro-vessels [10,11]. 
Hypercoagulable state (elevated antiphospholipid antibodies) [12] and 
other perturbations of the coagulation system (abnormal platelets and 
D-dimer) [13], including elevated inflammatory biomarkers [13] are all 
possible underlying mechanism for increased risk of stroke as well as 
worsening of symptoms in COVID-19. 
Although our hospital is stroke ready, these cases came outside 
the therapeutic window period hence they were not triaged to the 
hyperacute stroke pathway. The management of these patients were 
directed at preventing secondary brain injury. Although current data 
suggest use of prophylactic anticoagulation with low molecular weight 
heparin for COVID-19 inpatients, [14] these agents pose a risk of 
haemorrhagic transformation of ischaemic stroke hence treatment 
should be individualized. Neuro-critical care of stroke patients sometimes 
required mechanical ventilation. In patients with significant respiratory 
illness or failure, timely mechanical ventilation improves stroke outcome 
[15]. However, in SSA with limited resources, this might not be always 
feasible. Our first patient was offered the service, but the relatives 
declined. Certainly, COVID-19 adds another dimension to the already 
Figure 3: (A) MRI DWI revealed hyperintense signal in the right MCA territory which involved right fronto parietal temporal lobes as well as 
capsuloganglionic region, indicating abnormal fluid restriction in those areas; (B) 3D TOF MRA revealed extended right internal carotid (intracranial 
portion) stenosis with near-total occlusion of the right middle cerebral artery; (C) portable chest X-ray shows cardiomegaly and features of interstitial 
edema seen as bilateral parahilar and lower zone infiltrates
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5existing poor outlook of acute stroke care in SSA. More worrisome is 
the risk of infections to members of the stroke team thereby shrinking 
the already modest number of stroke professionals [16]. In our hospital, 
two members of our team fell ill during this period leading to a serious 
strain on the remaining stroke team members. Protected code stroke 
(PCS) initiative has been proposed to prevent this risk [17]. The key 
components of the protocol include infection control screening, use of 
droplets and contact personal protective equipment (PPE) and crisis 
resource management. The population must need also be continuously 
educated and reminded on the benefits of early hospital presentation of 
stroke cases.
Conclusion
While stroke remains a medical emergency requiring swift medical and 
surgical intervention, concurrent COVID-19 infection presents a new 
challenge that tilts the prognostic balance. Furthermore, the implications 
for stroke team and stroke ready hospitals in SSA have been highlighted. 
An effort at maintaining universal precautions and donning of appropriate 
PPE for every suspected patient is advised but we must not lose precious 
time on this endeavour. Time is still brain.
What is known about this topic
• COVID-19 associated neurological disorders including strokes 
are being reported;
• Most cases are reported outside sub-Saharan Africa;
• Many protocol to enhance prompt treatment and limit 
healthcare professional exposure are developed.
What this study adds
• The case series emphasized the peculiar challenges of stroke 
care during COVID-19 era in sub-Saharan Africa;
• Both haemorrhagic and ischaemic strokes are possible in the 
setting of COVID-19;
• Protected Code Stroke is emphasized to limit healthcare 
professional exposure.
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